BSE filing, BSE: 544930. Summary written from the filing by ALFA Finder's alert engine.
Injecto Polymers Ltd: key numbers
- Share price
- ₹92.90
- Market cap
- ₹193.1 Cr
- Revenue (annual)
- ₹375.5 Cr
- Net profit (annual)
- ₹16.01 Cr
- P/E (TTM)
- 12.1×Sector 43.1×
- Promoter holding
- 64.35%
- FII holding
- 8.41%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Injecto Polymers Ltd
All →Injecto Polymers Other Announcement
Injecto Polymers Ltd filed its quarterly shareholding pattern under Regulation 31. This is a routine compliance disclosure for shareholders.
Injecto Polymers Capital Structure Change
CapitalSquare Financial Services, a market maker, bought 958,800 Injecto Polymers shares (4.61%) on the open market, raising its stake to 5.97%. No transaction price was disclosed.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.